C 331 af 29. 10. 1998, s.
In addition variations were introduced to all 139 marketing authorisations and amendments made to the summary of product characteristics for all terfenadine 30 mg tablet, 60 mg tablet and 6 mg/ ml oral suspension formulations (OJ C 331, 29.10.1998, p.